Bulgarian stocks book best Q1 since the start of 2014

The main index of Bulgarian stocks SOFIX added 8.11% q/q in 1Q17, best performance since the start of 2014. The index booked fourth consecutive quarter on the upside adding 43% since the last down quarter – 3Q16. Generic drug pharma company Sopharma (3JR BU) contributed most to SOFIX’ performance over the quarter, adding 31% q/q… Read more

Sirma Group Holding

New research report: Sirma Group Holding – stepping up sales, R&D and streamlining

Sirma Group Holding missed FY2016 guidance but outperformed ELANA Trading analysts’ expectation. Growth accelerated in H2’16 allowing the Group to sustain sales performance above 20% y/y. Тop line expanded 22% y/y to BGN 41.5m as US sales advanced well together with strong domestic performance. Q3’16 was best in history followed by a strong Q4. Bottom… Read more

2017 dividend season started

2017 dividend season started

First dividend news came out with the publication of audited FY 2016 reports yesterday. Regular dividend providers REITs are investors’ favourites on dividends since by law they are obliged to distribute 90% of their profits as dividend. Biggest land REIT in Bulgaria Advance Terrafund (6A6BU) provisions BGN 0.154 DPS, yielding 7.3% at current quotes, according… Read more

Veselin Mareshki (photocredit: BGNES)

Mareshki, leader of Bulgarian nationalists’ party, lists a pharma company Pharmhold

Veselin Mareshki, leader of the Bulgarian nationalists’ party, lists Pharmhold (2PH BU), according to a notice by the Bulgarian Stock Exchange. Mareshki road to listing The Company has been aiming to list since 2015. Finally it received the right to apply for listing after battling the regulator’s denial to approve it as a public company… Read more

Sirma Group Holding online investors’ day

Sirma Group Holding presented 5-year forecast and US business development to investors

Sirma Group Holding (SKK BU) discussing new leaner structure and cloud, data and cognitive tech solutions as strategic areas of development – the Company announced that has been having meetings with key institutional investors in Bulgaria over the last two weeks discussing its new five year strategy post the 2015 IPO. Sirma Group Holding streamlining… Read more

Medica

Medica and Sopharma signed a revised merger agreement

Leading generic pharma producer Sopharma (3JR BU) and medical consumables producer Medica (5MA BU) signed a revised merger agreement, according to a regulatory filing with the stock exchange. Medica shareholders are getting 0.8831 Sopharma shares The revised agreement followed recommendations from the Financial Supervision Commission (FSC) based on the initial agreement filed for approval. Both… Read more

Stara Planina Hold

Stara Planina Hold’s management proposes 6% higher dividend in 2017

Industrial company Stara Planina Hold’s (5SR BU) management proposes dividend payouts for subsidiaries within the group from 2016 profits, according to a regulatory filing with the stock exchange. This is 20th consequent dividend payout for shareholders of Stara Planina Hold, M+S Hydravlic, Hydraulic Elements & Systems PLC since 1997 till now. With Elhim Iskra dividend… Read more

ELANA Trading has a 29 years of history on financial markets, offering a wide range of services and markets. ELANA Trading quality service has been recognized by 24 industry awards. The broker is part of the international brokers’ network of US Auerbach Grayson & Co. since 1998 and maintains long-term partnerships with a lot of international financial institutions.

ELANA Trading is part of ELANA group - one of the largest groups in the non-banking financial sector in Bulgaria.

Contacts

Dimitar Georgiev
Head of Trading
Phone: +359 (2) 81 000 25
Email: georgievd@elana.net

Tatyana Puncheva-Vasileva
Head of Research
Phone: +359 (2) 81 000 24
Email: vasileva@elana.net

Contacts

Sopharma Business Towers,
Tower B, Floors 12-13,
5, Lachezar Stanchev St,
1797 Sofia, Bulgaria

Phone: +359 (2) 81 000 25
Phone: +359 (2) 81 000 26
Email: bgtrader@elana.net
Disclaimer: This website represents ELANA Trading with the sole purpose to provide information. The data published on the website is not provided to be used as a background for specific investment decisions. No publication of ELANA Trading should be construed as an offer (or solicitation of an offer) to U.S. persons to buy or sell financial instruments or any financial product, make any investment or participate in any particular trading strategy (collectively “Offers”). No Publication of ELANA Trading should be construed as an Offer (or solicitation of an offer) in any jurisdiction in which such Offer would be illegal. Any such perceived Offer will not be honoured by ELANA Trading.

© 1991 - 2026 ELANA | ELANA Trading Privacy policy Change Cookie Preferences